GAMMA Investing »

Allogene Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2026-03-31 $37k 15k 2.44
2025-12-31 $18k 13k 1.37

More positions owned by GAMMA Investing

Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Amazon Common Stock (AMZN)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Ishares Inc Core Msci Emkt Etf (IEMG)
Tesla Common Stock (TSLA)
Ishares Tr National Mun Etf Etf (MUB)
Eli Lilly Common Stock (LLY)
Exxon Mobil Corp Common Stock (XOM)
Vanguard Bd Index Fds Intermed Term Etf (BIV)

View all positions for GAMMA Investing

Top funds holding Allogene Therapeutics

Pfizer
BlackRock
Tpg Gp A
Vanguard Group
PRIMECAP Management Company
Vanguard Capital Management
Citadel Advisors
Two Sigma Investments
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Patient Square Capital
Millennium Management
Candriam Luxembourg S.C.A.
Wildcat Capital Management

View all funds holding Allogene Therapeutics